Good Meghan L, Malekzadeh Parisa, Ruff Samantha M, Gupta Shreya, Copeland Amy, Pacak Karel, Nilubol Naris, Kebebew Electron, Patel Dhaval
Eunice Kennedy Shriver Surgery Oncology Program, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bldg 10, Rm 3W-5840, Bethesda, MD, 20892, USA.
National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
World J Surg. 2020 Feb;44(2):552-560. doi: 10.1007/s00268-019-05175-9.
Catecholamine excess in patients with pheochromocytomas or paragangliomas (PPGLs) can lead to hypertension, diabetes and hyperlipidemia. The aim was to investigate the prevalence of hyperlipidemia and the effect of surgical resection.
One hundred and thirty-two patients with PPGLs underwent an operation at the National Institutes of Health from 2009 to 2016, of which 54 patients met the inclusion criteria. Clinical demographics, BMI, genetic mutations, tumor size, perioperative catecholamine levels and perioperative lipid panels were retrospectively reviewed. Spearman correlation between catecholamines and lipid levels was evaluated. Paired Wilcoxon and paired t test were used to analyze differences in pre- and postoperative lipid levels.
Preoperatively, 51 patients (94.4%) had elevated catecholamines, thirteen (24.1%) had elevated total cholesterol (TC) (>200 mg/dL), nine (16.6%) had elevated LDL (>130 mg/dL) and ten (18.5%) had elevated triglycerides (>150 mg/dL). Serum and urinary metanephrine levels were positively associated with TC (r = 0.2792, p = 0.0372 and r = 0.4146, p = 0.0031, respectively) and LDL levels (r = 0.2977, p = 0.0259 and r = 0.4434, p = 0.0014, respectively). Mean TC decreased from 176.4 to 166.3 mg/dL (p = 0.0064) and mean HDL decreased from 56.7 to 53.2 mg/dL (p = 0.0253) after PPGL resection (median 3.1 months (range 1.3-50.2) between lipid panels). Most patients with elevated TC (76.9%) had improvement with mean TC decreasing from 225 to 200.2 mg/dL (p = 0.0230). Of patients with elevated LDL, 66.7% had improvement with mean LDL decreasing from 149 to 131.1 mg/dL (p = 0.0313).
The prevalence of hyperlipidemia in patients with PPGLs is 46%. Future prospective studies are needed to determine whether surgical resection improves TC and/or LDL levels.
嗜铬细胞瘤或副神经节瘤(PPGLs)患者体内儿茶酚胺过量可导致高血压、糖尿病和高脂血症。本研究旨在调查高脂血症的患病率及手术切除的效果。
2009年至2016年期间,132例PPGLs患者在美国国立卫生研究院接受了手术,其中54例符合纳入标准。回顾性分析患者的临床特征、体重指数、基因突变、肿瘤大小、围手术期儿茶酚胺水平和围手术期血脂指标。评估儿茶酚胺与血脂水平之间的Spearman相关性。采用配对Wilcoxon检验和配对t检验分析术前和术后血脂水平的差异。
术前,51例患者(94.4%)儿茶酚胺升高,13例(24.1%)总胆固醇(TC)升高(>200mg/dL),9例(16.6%)低密度脂蛋白(LDL)升高(>130mg/dL),10例(18.5%)甘油三酯升高(>150mg/dL)。血清和尿间甲肾上腺素水平与TC(分别为r = 0.2792,p = 0.0372和r = 0.4146,p = 0.0031)及LDL水平(分别为r = 0.2977,p = 0.0259和r = 0.4434,p = 0.0014)呈正相关。PPGL切除术后(两次血脂检测的中位间隔时间为3.1个月(范围1.3 - 50.2个月)),平均TC从176.4mg/dL降至166.3mg/dL(p = 0.0064),平均高密度脂蛋白(HDL)从56.7mg/dL降至53.2mg/dL(p = 0.0253)。大多数TC升高的患者(76.9%)病情改善,平均TC从225mg/dL降至200.2mg/dL(p = 0.0230)。LDL升高的患者中,66.7%病情改善,平均LDL从149mg/dL降至131.1mg/dL(p = 0.0313)。
PPGLs患者高脂血症的患病率为46%。未来需要进行前瞻性研究以确定手术切除是否能改善TC和/或LDL水平。